Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GFH018 |
| Trade Name | |
| Synonyms | GFH-018|GFH 018 |
| Drug Descriptions |
GFH018 inhibits TGFBR1, leading to decreased downstream signaling, and potentially resulting in modulation of immune response, decreased tumor cell migration, reduced angiogenesis, and antitumor activity (Cancer Res 2019;79(13 Suppl):Abstract nr 3072). |
| DrugClasses | TGFBR1 inhibitor 16 |
| CAS Registry Number | NA |
| NCIT ID | C181021 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| GFH018 | GFH018 | 0 | 0 |
| GFH018 + Toripalimab-tpzi | GFH018 Toripalimab-tpzi | 0 | 1 |